David Cunningham, Director at IMMUCELL CORP /DE/ (ICCC), bought 3,000 shares at $3.65 ($11K) on 2013-08-14, disclosed to the SEC on 2013-08-16.
Open-market purchase of $11k ICCC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.60 | 100 | $360 | 3.3% |
| 2 | $3.60 | 162 | $583 | 5.3% |
| 3 | $3.60 | 38 | $137 | 1.2% |
| 4 | $3.65 | 100 | $365 | 3.3% |
| 5 | $3.65 | 500 | $2K | 16.5% |
| 6 | $3.65 | 38 |
| $139 |
| 1.3% |
| 7 | $3.65 | 62 | $226 | 2.1% |
| 8 | $3.70 | 1,000 | $4K | 33.5% |
| 9 | $3.69 | 100 | $369 | 3.3% |
| 10 | $3.70 | 36 | $133 | 1.2% |
| 11 | $3.70 | 100 | $370 | 3.4% |
| 12 | $3.70 | 764 | $3K | 25.6% |
| Total | $3.68 avg | 3,000 | $11K | 100% |
| Filing → |
| ICCC | BUY | 2016-08-22 | $21K | — | Filing → |
| ICCC | BUY | 2016-02-01 | $10K | — | Filing → |
| ICCC | BUY | 2014-05-16 | $6K | — | Filing → |